Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: Evidence from a managed care database in the United States
BACKGROUND: Data on the clinical and economic burden of eosinophilic granulomatosis with polyangiitis (EGPA) are limited. OBJECTIVE: To assess the real-world clinical and economic outcomes of patients diagnosed with EGPA vs patients with asthma (present in > 90% of EGPA cases) receiving treatment...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academy of Managed Care Pharmacy (AMCP)
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |